Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan-Reference-Cited by-同舟云学术

Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan

Published:2021-09-02 Issue:1 Volume:115 Page:11-20
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ieko Masahiro^ORCID,Ohmura Kazumasa,Naito Sumiyoshi,Yoshida Mika,Saito Makoto,Kiyohara Kazuki,Miyazima Shinri,Maeta Takahiro,Ohtsu Akihiro,Shimosegawa Kenji,Takahashi Nobuhiko,Ichinose Akitada

Funder

The Ministry of Health Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-021-03212-9.pdf

Reference32 articles.

1. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. UK Haemophilia Centre Doctors’ Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007;109:1870–7.

2. Baudo F, Collins P, Huth-Kuhne A, Levesque H, Marco P, Nemes L, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012;120:39–46.

3. Kessler CM, Nemers L. Acquired inhibitors to factor VIII. In: Rodringuez EC, Lee CA, editors. Inhibitors in patients with haemophilia. Oxford: Blackwell Publishing; 2002. p. 98–112.